| Biological importance of the indole nucleus in recent years: a comprehensive review V Sharma, P Kumar, D Pathak Journal of Heterocyclic Chemistry 47 (3), 491-502, 2010 | 663 | 2010 |
| Indolizine: a biologically active moiety V Sharma, V Kumar Medicinal Chemistry Research 23, 3593-3606, 2014 | 228 | 2014 |
| Heterocyclic chalcone analogues as potential anticancer agents V Sharma, V Kumar, P Kumar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 94 | 2013 |
| In silico molecular docking analysis of natural pyridoacridines as anticancer agents V Sharma, PC Sharma, V Kumar Advances in Chemistry 2016 (5409387), 1-9, 2016 | 62 | 2016 |
| A Comprehensive Review on Fused Heterocyclic as DNA Intercalators: Promising Anticancer Agents V Sharma, M Gupta, P Kumar, A Sharma Current Pharmaceutical Design 27 (1), 15-42, 2021 | 36 | 2021 |
| A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry S Vikas, S Prabodh C, K Vipin Journal of Advanced Research 6 (1), 63-71, 2015 | 32 | 2015 |
| New thiazolidinyl analogs containing pyridine ring: synthesis, biological evaluation and QSAR studies R Ranga, V Sharma, V Kumar Medicinal Chemistry Research 22, 1538-1548, 2013 | 21 | 2013 |
| Pharmacophore Modelling and 3D-QSAR Studies on N3-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists P Kaur, V Sharma, V Kumar International Journal of Medicinal Chemistry 2012, 13, 2012 | 19 | 2012 |
| Heterocyclic analogues as kinase inhibitors: a focus review V Sharma, R Kamal, V Kumar Current topics in medicinal chemistry 17 (22), 2482-2494, 2017 | 16 | 2017 |
| Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines U Kaushik, V Sharma, V Kumar Medicinal Chemistry Research 21, 3777-3784, 2012 | 14 | 2012 |
| Designing of kinase hinge binders: A medicinal chemistry perspective V Sharma, M Gupta Chemical Biology & Drug Design 100 (6), 968-980, 2022 | 13 | 2022 |
| DNA intercalators as anticancer agents S Venugopal, V Sharma, A Mehra, I Singh, G Singh Chemical Biology & Drug Design 100 (4), 580-598, 2022 | 13 | 2022 |
| Indole Derived Anticancer Agents A Mehra, V Sharma, A Verma, S Venugopal, A Mittal, G Singh, B Kaur ChemistrySelect 7 (34), e202202361, 2022 | 12 | 2022 |
| Sulphur Containing Heterocyclic Compounds as Anticancer Agents B Kaur, G Singh, V Sharma, I Singh Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2023 | 6 | 2023 |
| Indolizidine Alkaloids: Prospective Lead Molecules in Medicinal Chemistry DKVK Vikas Sharma*, Raj Kamal Current Traditional Medicine 7 (1), 45-56, 2021 | 6 | 2021 |
| Pharmacophore mapping studies on indolizine derivatives as 15-LOX inhibitors V Sharma, V Kumar Bulletin of Faculty of Pharmacy, Cairo University 53 (1), 63-68, 2015 | 5 | 2015 |
| Efficient way of drug designing: a comprehensive review on computational techniques V Sharma, V Kumar Bull. Pharm. Res 4 (3), 118-23, 2014 | 5 | 2014 |
| Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review V Kumar, N Kaur, S Sahu, V Sharma, D Kumar, A Sharma, P Wadhwa Current Medicinal Chemistry 30 (13), 1464-1481, 2023 | 4 | 2023 |
| Pharmacophore mapping: prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones R Bajaj, V Sharma, V Kumar Bulletin of Faculty of Pharmacy, Cairo University 52 (1), 103-108, 2014 | 4 | 2014 |
| Pharmacophore modeling studies on xanthones as monoamine oxidase-A inhibitors H Bansal, A Sharma, V Sharma, V Kumar Bull. Pharm. Res 1 (1), 15-21, 2011 | 4 | 2011 |
Dr. Vipin KumarDepartment of Pharmacy, Central University of Rajasthanยืนยันอีเมลแล้วที่ curaj.ac.in
